Hepatocellular Carcinoma (HCC) Drugs refer to pharmaceutical compounds and therapies specifically designed for the treatment and management of hepatocellular carcinoma, the most common form of primary liver cancer. These drugs are developed to target cancer cells within the liver, inhibit tumor growth, and improve the prognosis and quality of life for individuals diagnosed with this aggressive and often challenging-to-treat cancer.
